| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2113463 | Cancer Letters | 2011 | 8 Pages |
Neural stem cells (NSCs) led to the development of a novel strategy for delivering therapeutic genes to tumors. NSCs expressing rabbit carboxyl esterase (F3.CE), which activates CPT-11, significantly inhibited the growth of MDA-MB-435 cells in the presence of CPT-11. F3.CE cells migrated selectively into the brain metastases located in the opposite hemisphere. The treatment also significantly decreased tumor volume in immune-deficient mice bearing MDA-MB-435 tumors when F3.CE cells were transplanted into the contralateral hemisphere. The survival rate was significantly prolonged with the treatment with F3.CE and CPT-11. This strategy may be considered as an effective treatment regimen for brain metastases.
► Human neural stem cells (NSCs) delivering therapeutic gene is used to treat brain metastasis of breast cancer. ► NSCs expressing a suicide gene carboxyl esterase migrated selectively into the brain tumor mass and killed tumor cells. ► The treatment significantly decreased tumor volume in brain metastasis of breast cancer, and prolonged animal survival. ► This stem cell-based suicide gene therapy could serve as an effective treatment for brain metastases of breast cancer.
